Molecular Mechanisms Underlying Protection Against H9N2 Influenza Virus Challenge in Mice by Recombinant Lactobacillus Plantarum with Surface Displayed HA2-LTB
Overview
Biotechnology
Authors
Affiliations
It has been considered that the Avian influenza virus (AIV) causes severe threats to poultry industry. In this study, we constructed a series of recombinant Lactobacillus plantarum (L. plantarum) with surface displayed hemagglutinin subunit 2 (HA2) alone or together with heat-labile toxin B subunit (LTB) from enterotoxigenic Escherichia coli. Balb/c mice were used as model to evaluate the protective effects of recombinant L. plantarum strains against H9N2 subtype challenge. The results showed that the presence of LTB significantly increased the percentages of CD3CD4IL-4, CD3CD4IFN-γ and CD3CD4IL-17 T cells, as well as CD3CD8IFN-γ T cells in spleen and MLNs determined by Fluorescence-Activated Cell Sorting assay. Similar increased production of serum IFN-γ was also confirmed by enzyme linked immunosorbent assay (ELISA). The L. plantarum with surface displayed HA2-LTB also dramatically increased the percentages of B220 IgA B cells in peyer patch, in consistent with elevated production of mucosal SIgA antibody determined by ELISA. Finally, the orally administrated HA2-LTB expressing strain efficiently protected mice against H9N2 subtype AIV challenge shown by increased survival percentages, body weight gains and decreased lung lesions in histopathologic analysis. In conclusion, this study provides more detail mechanisms underlying the adjuvant effects of LTB on heterologous antigen produced in recombinant lactic acid bacteria.
Ni X, Liu Y, Sun M, Jiang Y, Wang Y, Ke D Probiotics Antimicrob Proteins. 2024; .
PMID: 39251521 DOI: 10.1007/s12602-024-10360-x.
He G, Long H, He J, Zhu C Probiotics Antimicrob Proteins. 2024; 16(6):2229-2250.
PMID: 39101975 DOI: 10.1007/s12602-024-10338-9.
Bacterial Spore-Based Delivery System: 20 Years of a Versatile Approach for Innovative Vaccines.
Isticato R Biomolecules. 2023; 13(6).
PMID: 37371527 PMC: 10296236. DOI: 10.3390/biom13060947.
Recombinant lactic acid bacteria as promising vectors for mucosal vaccination.
Qiao N, Du G, Zhong X, Sun X Exploration (Beijing). 2023; 1(2):20210026.
PMID: 37323212 PMC: 10191043. DOI: 10.1002/EXP.20210026.
0111 Protects Against Influenza Virus by Modulating Intestinal Microbial-Mediated Immune Responses.
Xing J, Shi C, Sun M, Gu W, Zhang R, Chen H Front Microbiol. 2022; 13:820484.
PMID: 35847111 PMC: 9282045. DOI: 10.3389/fmicb.2022.820484.